Flupirtine Maleate

马来酸氟吡啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFlupirtine Maleate
Drug Alias Nameflupirtina马来酸氟吡定马来酸氟吡汀flupirtinum氟吡汀 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsPainMultiple Sclerosis, Relapsing-Remitting
Global Approved IndicationsPain
Approved Indications in ChinaPain
Original Approved Country/TerritoryGermany
Original Approved Date1986/01/01
Country/TerritoryGermanyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTeva Pharmaceuticals Polska Spółka Z Ograniczoną Odpowiedzialnością
Inactive CompaniesLudwig Maximilians University Of MunichCharite University, Berlin, GermanyUniversity Medicine Greifswald
Active IndicationsPain
Inactive IndicationsMultiple Sclerosis, Relapsing-Remitting

Other Information

ATC CodeN02BG07
Related LinksWikipediaDrugBankKEGG